We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Firestone Diamonds Plc | LSE:FDI | London | Ordinary Share | GB00BKX59Y86 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.20 | 0.15 | 0.25 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/7/2013 18:04 | " BK11 Mine Management decided to place the mine on temporary care and maintenance in February 2012 as a result of declining diamond prices which also resulted in an impairment charge of GBP13.2 million in the year ended 30 June 2012..." I fear that figure is correct! | b0xwellian | |
04/7/2013 09:19 | Andy, have they had their computers returned that were confiscated? | valentine | |
04/7/2013 09:07 | Header refers Is that -30.01 number in the profit column correct ? Did they make a 30m loss in 12 months ? FT says Income statement in GBP Year on year Firestone Diamonds PLC's net income fell 665.07% from a loss of 3.22m to a larger loss of 24.60m despite revenues that grew 165.72% from 2.45m to 6.52m. An increase in the cost of goods sold as a percentage of sales from 33.39% to 194.19% was a component in the falling net income despite rising revenues. View full income statement | buywell2 | |
02/7/2013 23:10 | bigglesbingham 2 Jul'13 - 17:29 - 1948 of 1948 If senior management are "doing the rounds" then why aren't they communicating with their other shareholders? The playing field is supposed to be level! I'm a shareholder and they have not communicated with me! "not performed well", you deserve the award for understatement of the millennium! | andy | |
02/7/2013 12:46 | Usual dearth of news from FDI! Management still drawing their salaries, so that's OK then! | andy | |
20/6/2013 09:34 | Are you stalking me ? I run around 8 threads I post what I like thanks You asked for the XEN to be closed You can ask for it to be opened .... but only on that thread Don't ask for what you don't want Cyprotex (CRX) now TOP advfn riser today With the FTSE down circa 1.5% | buywell2 | |
20/6/2013 09:22 | Andy - kindly do something about Bogwall's irrelevant post. He puts the same nonsense across multiple threads. | earnestwipplethwaiteiii | |
20/6/2013 09:04 | Dead right there Plus in general as GOLD takes a pasting on the back of USA QE reduction expectations Small Caps are now the place to be in my opinion .... as long as they are the RIGHT sector with the RIGHT CEO Commodity plays like FDI are now dead in the water as the chart shows ... COAL GOLD PLAT DIAMONDS IRON ZINC base metals and precious metals/stones .... only food water and necessaries for life are worth considering commodity wise. The Pharma Biotech sector is known a safe haven sector I think that sector will see some positive action in the year/s ahead as markets drop due to QE in the USA getting run down. DIAMOND has poo pooed Source BioScience (SBS) which has just reported an average increase in turnover of around 30% in the first half, they made a profit last year. Today Cyprotex (CRX) another small cap Pharma Bio have also released an RNS Now 2nd place riser today on advfn Recently there has been Instutional buying in Cyprotex Henderson Global and ORYX INTERNATIONAL GROWTH FUND LIMITED have recently bought 15% of Cyprotex shares Another Fund has bought just under 10% but we do not know who yet as such Institutional funds don't have to RNS till they go over 10% if they don't want to. So with regards to keeping the advfn community informed of other small and upcoming Pharma Biotechs as potential investments V loss making commodity stocks Cyprotex RNS out today with Market Update This little Pharma Biotech is going to make £1m profit this year but has a Mkt Cap of less than £10m ...... bit different to the loss making OXB A very encouraging update when one reads that the first half will NOT include any monies from the recent $10m contract just awarded by th USA Environmental Protection Agency for carrying out Toxicology tests on their library of chemical compounds in ToxCast3 ( Cellumen/Apredica now both part of Cyprotex won work in ToxCast1 and ToxCast2 ) So the second half of the year will include monies from this contract as work has now commenced. I thus think £1m profit is now on the cards. The acquisition of Apredica(Cellumen) resulted in Cyprotex gaining unique IP which has catapulted them into TOP SPOT in the WORLDS TOXICOLOGY CRO RANKINGS As my thread title says ..... cos I knew it would Cyprotex PLC Trading update 20th June 2013 Trading Update - H1 2013 Cyprotex PLC, a specialist ADME-Tox Contract Research Organisation providing screening services to the pharmaceutical, biotechnology, agrochemical and cosmetic industries, today provides a trading update for the half year ending 30 June 2013. Financial update Cyprotex can confirm that trading for the half year ending 30 June 2013 is anticipated to exceed the Board's expectations. Total revenues for H1 2013 are expected to be in the range of GBP4.25 million to GBP4.45 million (2012: H1 GBP3.72 million), an increase of approximately 14% to 20% on the comparative period. The revenue performance is encouraging across all of our geographical markets and our main service operations of high through put ADME, customised ADME and toxicology. The recently awarded Environmental Protection Agency (EPA) ToxCast contract, worth up to $10 million over 5 years, is unlikely to yield any revenues in the half year ending 30 June 2013 and its potential impact is not considered in this trading update. Operating costs for the first six months of 2013, on a pre-exceptional basis, are anticipated to be in line with the Board's expectations. Consequently, as a highly operationally geared company, Cyprotex is expecting to post a record half year operating profit for H1 2013 in the order of GBP200,000 to GBP300,000 (2012: H1 operating loss GBP189,000). Outlook The historical 45%:55% split for trading revenues is expected to continue in 2013. Market expectations for total revenues are GBP9.5 million for the year ending 31 December 2013, with an operating profit of GBP0.8 million. With sound fiscal controls applying over all operational costs, the Board believes that operating profitability for the full year 2013 is anticipated to be in line with current market expectations prior to any potential impact from the EPA contract. The Company is currently scheduled to issue its interim results for the half year ending 30 June 2013 on Wednesday 7 August 2013. Dr Anthony Baxter, CEO of Cyprotex, commented: "We are very pleased to report that trading is ahead of expectations for the first half of 2013. Our stated strategy to widen our service offerings is beginning to bear fruit. We are providing more customised ADME assays for pharma company clients and expanding our new toxicology offerings to all our customers. Our focus remains to deliver the highest quality data, as rapidly and as cost effectively as we can." | buywell2 | |
18/6/2013 08:29 | bsg, Yes it's apparent that many junior AIM and TSX.V companies are lifestyle vehicles for management and little else. When you look at the salaries paid by FDI over the years, and the loss of shareholder value, it's quite breathtaking, IMHO. | andy | |
17/6/2013 09:26 | The delay in FDI coming up with any result in raising finance means they are getting no joy. Not surprising though ... to raise $180m with a market cap of $25m takes some doing Existing shareholders will be left with next to no equity if the BOD find a Chinese bank/company to stump up the lolly assuming they like blue diamonds | buywell2 | |
17/6/2013 09:03 | bageo, There's still time! And the Trans Hex marine gravel project should be starting soon! They are going ship the diamonds to their Avontuur processing plant! And the resulting cashflow is going to fund Groen River 2! All to play for then? One day Rodders, one day! | andy | |
16/6/2013 21:27 | Andy Certainly true that 'Project remains strategically important for Debswana'. Admitting that ideas had reached the point of not delivering has never been a strong point. Still waiting for that USA Diamond project update! | bageo | |
14/6/2013 10:07 | Sep 2nd 2010 FDI Trading statement. Jwaneng Tailings Project +----+----------+--- | | - | Debswana to delay implementation of the project due | | | | to other priorities | +----+----------+--- | | - | Project remains strategically important for Debswana | +----+----------+--- | | - | Work expected to resume as soon as Debswana's other | | | | priorities allow | andy | |
14/6/2013 09:55 | Bageo, Surely FDI should RNS the fact that the tailings project is no longer postponed, but now gone as Debswana are doing it themselves? | andy | |
13/6/2013 21:12 | Plaudits to bageo on the ramper's thread. :-) bageo 13 Jun'13 - 20:23 - 10531 of 10531 0 0 Another of FDI's 'projects' which never benefited shareholders. When I mentioned that this project was "finished" a certain poster commented that it was simply "postponed"! Oh dear! | andy | |
13/6/2013 20:23 | Another of FDI's 'projects' which never benefited shareholders. hxxp://www.miningwee | bageo | |
13/6/2013 13:25 | Firestone in today's Shares mag - in a feature on why price targets are so different than current share price. Gives insight into how Firestone will get funding including new strategic investor talks... hxxp://www.sharesmag | dell1234 | |
13/6/2013 08:16 | macca, If you made a profit here I salute you! I don't know anyone else that has! | andy | |
12/6/2013 20:19 | Andy i am not in fdi any more, i am one of the few who made a small hard earned profit, i still pop in occasionally to check it out, | macca42 | |
11/6/2013 23:18 | macca42, Excellent link. Shame the FDI CFO is based in S.Africa! If you want to speak to him buy a calling card or use Skype....... | andy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions